Uncovering Silent Fungal Infections complicating Obstructive Uropathy due to Renal Papillary Necrosis in Diabetic patients – A step towards preventing Recurrent Obstructive Uropathy.
Main Article Content
Abstract
Introduction and Objectives: Renal papillary necrosis is one of the common causes of obstructive uropa-thy in diabetic patients. During removal of necrosed renal papilla, many patients were observed to have fluffy necrotic material in the ureter, and renal pelvis, and a few among them present again with recurrent episodes of obstructive uropathy and sepsis following DJ stent removal. Our study aimed to identify the
significance of this fluffy necrotic material and its evaluation by histopathological examination (HPE). Materials and Methods: This is a prospective observational study done in our institute by compiling data of 56 patients admitted with obstructive uropathy secondary to renal papillary necrosis who underwent a protocol-based treatment from 2016 to 2019. All these patients underwent initial DJ stenting followed by check flexible ureteroscopy or nephroscopy after 6 weeks. The white, necrotic fluffy material collected during initial DJ stenting or with subsequent flexible ureteronephroscopy was sent for HPE. All these patients were followed up for 1-3 years.
Results: Out of 56 patients, 15 patients had fluffy necrotic material in the bladder on initial cystoscopy, of which 1 patient was diagnosed with aspergillosis and 1 patient with candida infection on HPE. During check flexible ureteroscopy (FU), 19 patients had minimal burden of fluffy necrotic material in renal pelvis, of which one patient was diagnosed with aspergillosis, one with candida (same patient diagnosed on cystoscopy), and one patient with both aspergillus and candida colonies on HPE. 5 patients had the significant burden of fluffy necrotic material in the renal pelvis, requiring removal via percutaneous nephroscopic access. Among these 5 patients, 2 were diagnosed with aspergillosis and 1 with candida infection on HPE. A total of 32 patients had single papilla, and 24 had multiple papillae in the pelvicalyceal system. 5 out of 7 patients with positive fungal pathology had negative fungal cultures. Compared to our historical data of 4% mortality and 22% recurrent obstructive uropathy in the 3 years preceding the adoption of this protocol, with the present protocol, no patient developed recurrent pyelonephritis during follow-up of 1–3 years after DJ stent removal following complete evacuation of necrotic material and appropriate antifungal treatment.
Conclusion: This study highlights the need for check ureterorenoscopy and removal of all necrotic papillae and debris to establish a microbiological and histopathological diagnosis along with proper antifungal treatment to prevent episodes of recurrent pyelonephritis and obstructive uropathy.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.
References
2. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341(25):1906–1912.
3. Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmeno-pausal women. Am J Epidemiol 2005;161(6):557–564.
4. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26(2):510–513.
5. Kofteridis DP, Papadimitraki E, Mantadakis E, et al. Effect of diabetes mellitus on the clinical and micro-biological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc 2009;57(11):2125–2128.
6. Mnif MF, Kamoun M, Kacem FH, et al. Complicated urinary tract infections associated with diabetes mel-litus: pathogenesis, diagnosis and management. Indian J Endocrinol Metab 2013;17(3):442–445.
7. Wise GJ, Silver DA. Fungal infections of the genitourinary system. J Urol 1993; 149: 1377–1388
8. Gupta KL, Joshi K, Sud K et al. Renal zygomycosis: an
underdiagnosed cause of acute renal failure. Nephrol Dial Transplant 1999;14: 2720–2725
9. Abdulhayoglu S., Marble A. Necrotizing renal papil-litis (papillary necrosis) in diabetes mellitus. Am J Med Sci 1964 Dec;248:623-32.
10. Jung DC, Kim SH. Jung SI, et al. Renal Papillary Necrosis: Review and Comparison of Findings at Multi–Detector Row CT and Intra-venous Urography. RadioGraphics 2006 26:6, 1827-1836.
11. Mitchell KM. Co-existing bacterial pyelonephritis and bilateral ureteral fungus balls in a diabetic patient. Case report. J Fla Med Assoc 1990;77(6):596-599.
12. Fisher JF. Candida urinary tract infections—epidemiology, pathogenesis, diagnosis, and treatment: executive summary. Clin Infect Dis 2011;52:S429–32.
13. Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am 2014 Mar;28(1):61–74.
14. Colodner R, Nuri Y, Chazan B, et al. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis 2008;27:301–5.
15. Chitale SV, Shaida N, Burtt G, et al. Endoscopic manage-ment of renal candidiasis. J Endourol 2004;18:865–6.
16. Patterson TF, Thompson GR, Denning DW, et al. Prac-tice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–e60
17. Gupta KL: Fungal infections and the kidney. Indian J Nephrology 2001;11:147-154.
18. Jenks, J.D.; Hoenigl, M. Treatment of Aspergillosis. J Fungi 2018;4:98.